26 Jan 2013
Peginterferon beta-1a is a new molecular entity in which interferon beta-1a is pegylated to extend its half-life and prolong its exposure in the body, enabling study of a less frequent dosing schedule. The ADVANCE study ...
CoI: multiple, The Royal London Hospital was a site in the ADVANCE study.